Hypercalcemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis.

A patient on maintenance hemodialysis had widely disseminated tuberculosis, hypercalcemia, and elevated levels of calcitriol (1,25-dihydroxycholecalciferol). Hypercalcemia was not observed until the eighth month of hemodialysis, when persistent fevers began. At the end of a calcium-free dialysis, the plasma calcium concentration decreased to 6.6 mg/dL (1.65 mmol/L). The baseline calcitriol level was 56 pg/mL (normal, 19 to 50 pg/mL) and increased to 147 pg/mL at the end of hemodialysis. Parathyroid hormone levels by three separate assays did not appreciably increase during the hypocalcemia induced by the calcium-free hemodialysis. The serum phosphate concentration decreased from 7.3 to 4.5 mg/dL (2.36 to 1.45 mmol/L). Extrarenal production of calcitriol may occur in disseminated tuberculosis and may be stimulated by hypocalcemia and reduced serum phosphate. The expected parathyroid hormone response to hypocalcemia may have been inhibited by persistently elevated calcitriol levels or preexisting hypercalcemia.

[1]  E. Hendler,et al.  Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. , 1984, The New England journal of medicine.

[2]  H. Harter,et al.  Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. , 1984, The Journal of clinical investigation.

[3]  A. Barbato,et al.  Hypercalcemia associated with silicone-induced granulomas. , 1984, The New England journal of medicine.

[4]  T. Yasuda,et al.  1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders. , 1984, Endocrinologia japonica.

[5]  T. Clemens,et al.  Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. , 1984, The Quarterly journal of medicine.

[6]  D. Andress,et al.  Parathyroid hormone and bone histology: response to hypocalcemia in osteitis fibrosa. , 1984, Kidney international.

[7]  M. S. Parker,et al.  Hypercalcemia in coccidioidomycosis. , 1984, The American journal of medicine.

[8]  S. Adami,et al.  Suppression of secondary hyperparathyroidism in uraemia: acute and chronic studies. , 1984, British medical journal.

[9]  D. Andress,et al.  Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. , 1983, Kidney international.

[10]  U. Binswanger,et al.  Rapidity of plasma 1,25-dihydroxyvitamin D responses to hypo- and hypercalcemia in steers. , 1983, Endocrinology.

[11]  M. Holick,et al.  Normocalcemia in a hypoparathyroid patient with sarcoidosis: evidence for parathyroid-hormone-independent synthesis of 1,25 dihydroxyvitamin D. , 1983, Annals of internal medicine.

[12]  J. Eisman,et al.  A TEST OF 1,25‐DIHYDROXYVITAMIN D3 SECRETORY CAPACITY IN NORMAL SUBJECTS FOR APPLICATION IN METABOLIC BONE DISEASES , 1983, Clinical endocrinology.

[13]  H. DeLuca,et al.  1,25-dihydroxyvitamin D3-treated hypoparathyroidism: 35 patients years in 10 children. , 1982, The Journal of clinical endocrinology and metabolism.

[14]  A. Norman,et al.  Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. , 1981, The New England journal of medicine.

[15]  M. Haussler,et al.  The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. , 1981, The New England journal of medicine.

[16]  G. Lester,et al.  Vitamin D and pregnancy: the maternal-fetal metabolism of vitamin D. , 1981, Endocrine reviews.

[17]  N. Bell,et al.  Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. , 1980, The Journal of clinical investigation.

[18]  J. Eisman,et al.  Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D. , 1980, The American journal of physiology.

[19]  M. Friedberg,et al.  Serum 1,25-DihydroxycholecalciferoI in Anephric, Haemodialyzed and Kidneytransplanted Patients , 1980 .

[20]  A. Norman,et al.  Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and hypocalcemia in man. , 1980, The Journal of clinical endocrinology and metabolism.

[21]  J. Eisman,et al.  MODULATION OF PLASMA 1,25-DIHYDROXYVITAMIN D IN MAN BY STIMULATION AND SUPPRESSION TESTS , 1979, The Lancet.

[22]  J. Lemann,et al.  The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults. , 1979, The Journal of clinical endocrinology and metabolism.

[23]  S. Farah,et al.  Hypercalcemia in active pulmonary tuberculosis. , 1979, Annals of internal medicine.

[24]  H. DeLuca,et al.  Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjects. , 1978, The New England journal of medicine.

[25]  J. G. Hurst,et al.  Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves. , 1978, Endocrinology.

[26]  J. C. Lee,et al.  Hypercalcemia in disseminated coccidioidomycosis. , 1977, The New England journal of medicine.

[27]  H. DeLuca,et al.  Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. , 1977, Analytical biochemistry.

[28]  R. Freeman,et al.  Histoplasmosis with hypercalcemia, renal failure, and papillary necrosis. Confusion with sarcoidosis.. , 1977, JAMA.

[29]  H. DeLuca,et al.  A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. , 1976, Archives of biochemistry and biophysics.

[30]  J. Habener,et al.  Parathyroid hormone secretion in vivo. Demonstration of a calcium-independent nonsuppressible component of secretion. , 1976, The Journal of clinical investigation.

[31]  M. Haussler,et al.  THE ASSAY OF 1α, 25‐DIHYDROXYVITAMIN D3: PHYSIOLOGIC AND PATHOLOGIC MODULATION OF CIRCULATING HORMONE LEVELS , 1976, Clinical endocrinology.

[32]  J. Wergedal,et al.  Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat , 1975, Science.

[33]  J. Wergedal,et al.  Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. , 1975, The Journal of clinical investigation.

[34]  U. Binswanger,et al.  Acute parathyroid hormone response: sensitivity, relationship to hypocalcemia, and rapidity. , 1974, Endocrinology.

[35]  S. Massry,et al.  1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure. , 1974, Annals of internal medicine.

[36]  S. Braman,et al.  Steroid-responsive hypercalcemia in disseminated bone tuberculosis. , 1973, Archives of internal medicine.

[37]  D. Fraser,et al.  Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. , 1973, Nature: New biology.

[38]  S. Wallach,et al.  Hypercalcemia in mycobacterial infection. , 1972, The Journal of clinical endocrinology and metabolism.

[39]  H. DeLuca,et al.  Vitamin D Metabolism: The Role of Kidney Tissue , 1971, Science.

[40]  D. Fraser,et al.  Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite , 1970, Nature.

[41]  J. Stoeckle,et al.  Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature. , 1969, The American journal of medicine.

[42]  O. Bergeim,et al.  CALCIUM IN THE BLOOD IN TUBERCULOSIS , 1917 .

[43]  E. Frenkel,et al.  Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. , 1984, Annals of internal medicine.

[44]  V. Batuman,et al.  Elevated 1,25-dihydroxyvitamin D levels: occurrence with sarcoidosis with end-stage renal disease. , 1982, Archives of internal medicine.